FOLR1 and leukemia: We confirmed FOLR1 expression by the AML cells that engrafted in the unmodified T cell–treated mice and in one of the CAR T–treated mice that developed symptomatic leukemia on day 180 after T cell injection (Figure 7G and Supplemental Figure 15).